Cho, J.J.* ; Xu, Z.* ; Parthasarathy, U.* ; Drashansky, T.T.* ; Helm, E.Y.* ; Zuniga, A.N.* ; Lorentsen, K.J.* ; Mansouri, S.* ; Cho, J.Y.* ; Edelmann, M.J.* ; Duong, D.M.* ; Gehring, T. ; Seeholzer, T. ; Krappmann, D. ; Uddin, M.N.* ; Califano, D.* ; Wang, R.L.* ; Jin, L.* ; Li, H.* ; Lv, D.* ; Zhou, D.* ; Zhou, L.* ; Avram, D.*
Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation.
Nat. Commun. 10:701 (2019)
Polyubiquitination promotes proteasomal degradation, or signaling and localization, of targeted proteins. Here we show that the E3 ubiquitin ligase Hectd3 is necessary for pathogenic Th17 cell generation in experimental autoimmune encephalomyelitis (EAE), a mouse model for human multiple sclerosis. Hectd3-deficient mice have lower EAE severity, reduced Th17 program and inefficient Th17 cell differentiation. However, Stat3, but not ROR gamma t, has decreased polyubiquitination, as well as diminished tyrosine-705 activating phosphorylation. Additionally, non-degradative polyubiquitination of Malt1, critical for NF-kappa B activation and Th17 cell function, is reduced. Mechanistically, Hectd3 promotes K27-linked and K29-linked polyubiquitin chains on Malt1, and K27-linked polyubiquitin chains on Stat3. Moreover, Stat3 K180 and Malt1 K648 are targeted by Hectd3 for non-degradative polyubiquitination to mediate robust generation of ROR gamma t+ IL-17A(hi) effector CD4(+) T cells. Thus, our studies delineate a mechanism connecting signaling related polyubiquitination of Malt1 and Stat3, leading to NF-kB activation and ROR gamma t expression, to pathogenic Th17 cell function in EAE.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Ror-gamma-t; Nf-kappa-b; Growth-factor-beta; Paracaspase Malt1; T-h-17 Cells; Interleukin-17 Production; Gene-expression; T(h)17 Cells; Ubiquitin; Receptor
Keywords plus
Language
english
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 10,
Issue: 1,
Pages: ,
Article Number: 701
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Research Unit Signaling and Translation (SAT)
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-509800-002
Grants
Copyright
Erfassungsdatum
2019-03-13